- Chipmaker Sees Options Upside After a Strong Sector Report
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- I'm 'Extremely Bullish' on the Credit Markets: 5-Star Manager
- GE-Vivendi Deal Good for GE Finance, Comcast: Market Pro
- How Long Will This Health Care Firm's Rally Last?
- Dubai a 'Wake Up Call'—Expect Volatility Now: Market Pro
- We're Approaching a Market Bubble: Portfolio Manager
- Hershey Shares: What Options Are Saying
MOST SHARED
- Kohlberg Kravis Bidding for Morgan Stanley's CICC Stake
- Cisco Has 84% of Tandberg, Won't Extend Bid
- Case Closed but Woods Scrutiny Continues
- UK Economy Turned, Inflation to Spike: BoE Economist
- Keeping America Great
- Australia Regulator Opposes Caltex-Exxon Deal
- GE, Comcast Complete Deal Over NBC Universal: Source
- Toyota Takes Lead Position in Canada in November
- Treasury Assistance Comes at High Price For GM
- Unemployment to Peak at 10.5%: Moody's Economist
- 8 Stocks to Gain on Obama's Afghan Plan: Analysts
- BofA On Proposed Changes In The Housing Bailout Program
- The Future of The Media Landscape
- November Auto Sales Muddle Along
- Busch: What Obama Won't Say Tonight
- Stick with Equities—Avoid Emerging Markets: Laszlo Birinyi
- Pfizer Chomps On A Carrot
- Job Cuts Fall to Lowest in Nearly 2 Years: Challenger
- Wal-Mart Targets Video Games with Latest Price Cuts
- 'Black Swan' Shuns Public Life Because of Bernanke
- Look Ahead: Markets Count Down to US Jobs Report
- Dubai World To Meet with Creditors Next Week
- FHA to Toughen Mortgage Rules in Lenders Crackdown
- Obama to Send More Troops; Seeks Afghanistan Exit
- GM Removes CEO Henderson; Whitacre Is Interim Chief
- UK Economy Turned, Inflation to Spike: BoE Economist
RSS FEED
CNBC Stock Blog
Text Size 
This is not your garden-variety recession, and Ken Kam of Marketocracy Masters 100 says it means the market of the future will be a lot different from the market of the past.
"The market has fundamentally changed," he told CNBC. "A lot of people who are holding onto stocks, hoping that when things get back to normal that their stocks will get back to even, I think are going to be surprised."
He sees new sectors leading the market when it does come back. So what sectors is he talking about, and whose stocks does he like in those sectors?
Recommendations:
Start with health care, and DepoMed [DEPO
Loading...
()
], a name not often mentioned.
"DepoMed is a small-cap biotech stock," he said. "Biotech and pharmaceuticals are bright spots, because pharmaceuticals have very strong cash flow, so of all industries they have the least need for bank financing."
Kam concedes the sector, too, must change, as patented products go generic, and he sees DepoMed as a prime candidate for acquisition, in a consolidation wave that just saw Pfizer [PFE
Loading...
()
] acquire Wyeth [WYE
Loading...
()
].
"I woult put Cephalon [CEPH
Loading...
()
] in the same category," he added.
He also likes Novo Nordisk [NOVO
Loading...
()
].
Disclosures:
Disclosure information for Ken Kam was not immediately available.
Data is a real-time snapshot *Data is delayed at least 15 minutes